DaunoXome package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

On August 3, 2017, the U.S. Food and Drug Administration granted regular approval to a liposome-encapsulated combination of daunorubicin and cytarabine (VYXEOS, Jazz Pharmaceuticals, Inc.)...

Daunorubicin binds and intercalates between DNA base pairs. Inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, resulting in single and double strand DNA breaks.

Liposomal daunorubicin (trade name DaunoXome) is a chemotherapy drug that is FDA approved to treat AIDS related Kaposi's sarcoma. It is also commonly used to treat specific types of leukaemia and …

Class: Chemotherapy Generic Name: Liposomal daunorubicin (lip-oh-ZOE-mel don-oh-ROO-bi-sin) Trade Name: DaunoXome® How is this drug used? Liposomal daunorubicin is FDA approved for the …

What Is Daunorubicin Liposomal Used For and How Does it Work? Daunorubicin liposomal is used to treat advanced HIV-associated kaposi sarcoma. As of July 20, 2016, the Food and Drug …

In animal studies, daunorubicin has been shown to accumulate in tumors to a greater extent when administered as DaunoXome than when administered as daunorubicin. Once within the tumor …

Liposomal daunorubicin (Other Names: DaunoXome) is given intravenously (IV) treat cancer. Find side effects, allergic reactions, and food and drug interactions.

Easy-to-read patient leaflet for Daunorubicin (Liposomal). Includes indications, proper use, special instructions, precautions, and possible side effects.

Daunorubicin citrate liposomal injection is a cytotoxic drug. Therefore, a Bio-IND is required for a bioequivalence study of daunorubicin citrate liposomal injection to ensure the safety...